Filtros de búsqueda

Lista de obras de

A Phase II Study of Trastuzumab Emtansine in HER2-positive Non-Small-Cell Lung Cancer

artículo científico publicado en 2017

A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) Trial 0

A case of advanced non-small-cell lung cancer who responded slowly to gefitinib monotherapy after long-term disease stabilization

artículo científico publicado en 2009

A case of colorectal cancer with double-activating epidermal growth factor receptor mutations

artículo científico publicado en 2011

A case of pneumonitis induced by CDDP and 5-FU

artículo científico publicado en 2005

A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndrome

artículo científico publicado en 2013

A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene

artículo científico publicado en 2014

A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer

artículo científico publicado en 2006

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer

artículo científico publicado en 2004

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer

artículo científico publicado en 2005

A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer

artículo científico publicado en 2010

A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer

artículo científico publicado en 2008

A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen

artículo científico publicado en 2011

A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404.

artículo científico publicado en 2017

A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0801.

artículo científico publicado en 2014

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401.

artículo científico publicado en 2011

A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.

artículo científico publicado en 2014

A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102.

artículo científico publicado en 2016

A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403

scientific article published on 01 October 2018

A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202.

artículo científico publicado en 2017

A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer

artículo científico publicado en 2007

A phase II trial of erlotinib monotherapy in pretreated patients with advanced non-small cell lung cancer who do not possess active EGFR mutations: Okayama Lung Cancer Study Group trial 0705.

artículo científico publicado en 2010

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors

artículo científico publicado en 2002

A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factors

artículo científico publicado en 2018

A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer

artículo científico publicado en 2008

A relapse of small-cell lung cancer ten years after concomitant chemoradiotherapy followed by high-dose chemotherapy with autologous peripheral blood stem cell transfusion

artículo científico publicado en 2011

A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation

A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901).

artículo científico publicado en 2014

A survey of Japanese thoracic oncologists' perception of diagnostic and treatment strategies for EGFR mutant or EML4-ALK fusion non-small cell lung cancer

artículo científico publicado en 2014

Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma

artículo científico publicado en 2012

Aberrant promoter hypermethylation in serum DNA from patients with silicosis

artículo científico publicado en 2008

Abrupt enlargement of adrenal incidentaloma: a case of isolated adrenal metastasis

artículo científico publicado en 2005

Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutation

artículo científico publicado en 2007

Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer

artículo científico publicado en 2006

Advantage of Induction Chemoradiotherapy for Lung Cancer in Securing Cancer-Free Bronchial Margin

artículo científico publicado en 2017

Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model

artículo científico publicado en 2013

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3.

artículo científico publicado en 2015

An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report

artículo científico publicado el 10 de julio de 2011

An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer

artículo científico publicado en 2004

Association between poor performance status and risk for toxicity during erlotinib monotherapy in Japanese patients with non-small cell lung cancer: Okayama Lung Cancer Study Group experience

artículo científico publicado en 2010

Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer

artículo científico publicado en 2008

Basal segmental auto-transplantation after pneumonectomy for advanced central lung cancer

artículo científico publicado en 2012

Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007

article

CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study

artículo científico publicado en 2013

Can dose-dense chemotherapy improve outcome in patients with better-prognosis small-cell lung cancer?

artículo científico publicado en 2005

Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan

artículo científico publicado el 1 de octubre de 2010

Cavitary pulmonary involvement of diffuse large B-cell lymphoma transformed from extra nodal marginal zone B-cell lymphoma MALT type

artículo científico publicado en 2011

Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset

artículo científico

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

artículo científico publicado en 2017

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients with Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

artículo científico publicado en 2002

Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice

artículo científico publicado en 2009

Chemotherapy for lung cancer: still alive!

artículo científico publicado en 2015

Cisplatin down-regulates topoisomerase I activity in lung cancer cell lines.

artículo científico publicado en 2004

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation

artículo científico publicado en 2014

Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients

artículo científico publicado en 2004

Clinical characteristics of Japanese candidates for lung transplant for interstitial lung disease and risk factors for early death while on the waiting list

artículo científico

Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancer

artículo científico publicado en 2006

Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group

artículo científico publicado en 2012

Clinical significance of epidermal growth factor receptor gene mutations on treatment outcome after first-line cytotoxic chemotherapy in Japanese patients with non-small cell lung cancer

artículo científico publicado en 2007

Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer: experience at a single institution

artículo científico publicado en 2006

Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult

scientific article published on October 2007

Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer

artículo científico publicado en 2002

Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.

artículo científico publicado en 2003

Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial

artículo científico publicado en 2016

Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions

Comparison of chemosensitivity tests: clonogenic assay versus MTT assay

artículo científico publicado en 2002

Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience

artículo científico publicado en 2010

Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma

artículo científico publicado en 2004

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer

artículo científico publicado en 2009

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC).

artículo científico publicado en 2017

Correlation of plasma crizotinib trough concentration with adverse events in patients with anaplastic lymphoma kinase positive non-small-cell lung cancer

artículo científico publicado en 2015

Cure- or Care-Oriented Regimen for Stage III Non–Small-Cell Lung Cancer?

Current status and future perspectives of cooperative study groups for lung cancer in Japan

artículo científico publicado en 2014

Cytotoxicity of activated natural killer cells and expression of adhesion molecules in small-cell lung cancer

artículo científico publicado en 2012

DNA methylation in small lung adenocarcinoma with bronchioloalveolar carcinoma components

artículo científico publicado en 2009

Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancer

artículo científico publicado en 2002

Desire for information and involvement in treatment decisions: lung cancer patients' preferences and their physicians' perceptions: results from Okayama Lung Cancer Study Group Trial 0705.

artículo científico publicado en 2010

Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay

artículo científico publicado en 2006

Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients

artículo científico publicado en 2008

Detection of the EGFR mutation in exhaled breath condensate from a heavy smoker with squamous cell carcinoma of the lung

artículo científico publicado en 2011

Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of cisplatin accumulation and topoisomerase I activity

artículo científico publicado en 2005

Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience

artículo científico publicado en 2016

Disappearance of an activated EGFR mutation after treatment with EGFR tyrosine kinase inhibitors

artículo científico publicado en 2012

Discomfort during bronchoscopy performed after endobronchial intubation with fentanyl and midazolam: a prospective study

artículo científico publicado en 2017

Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation

artículo científico publicado en 2013

Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer

scientific article published on 01 October 2018

Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model

artículo científico publicado en 2015

Dramatic effect of ZD1839 ('Iressa') in a patient with advanced non-small-cell lung cancer and poor performance status

artículo científico publicado en 2003

EGFR Mutation, But Not Sex and Smoking, Is Independently Associated with Favorable Prognosis of Gefitinib-treated Patients with Lung Adenocarcinoma

EGFR mutation and response of lung cancer to gefitinib

artículo científico publicado en 2005

EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib

artículo científico publicado en 2007

ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer

artículo científico publicado en 2007

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model

artículo científico publicado en 2013

Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene Mutation

artículo científico publicado en 2016

Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer

artículo científico publicado en 2004

Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice

artículo científico publicado en 2009

Effects of (-)-epigallocatechin-3-gallate on EGFR- or Fusion Gene-driven Lung Cancer Cells

artículo científico publicado en 2017

Effects of different combinations of gefitinib and irinotecan in lung cancer cell lines expressing wild or deletional EGFR.

artículo científico publicado en 2006

Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivo

artículo científico publicado en 2009

Efficacy of a lumbo-peritoneal shunt for meningeal carcinomatosis refractory to gefitinib treatment.

artículo científico publicado en 2009

Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation

artículo científico publicado en 2016

Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non small cell lung cancer cell line

artículo científico publicado en 2007

Endobronchial ultrasound-guided transbronchial biopsy with or without a guide sheath for diagnosis of lung cancer

artículo científico publicado en 2014

Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography

scientific article published on 22 March 2016

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma

artículo científico publicado en 2008

Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell line.

artículo científico publicado en 2004

Establishment of pemetrexed-resistant non-small cell lung cancer cell lines

artículo científico publicado en 2011

Everolimus prolonged survival in transgenic mice with EGFR-driven lung tumors

artículo científico publicado en 2014

Expression of minor histocompatibility antigen, HA-1, in solid tumor cells

artículo científico publicado en 2002

Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience

artículo científico publicado en 2014

Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report

artículo científico publicado en 2014

Fever after lung radiofrequency ablation: Prospective evaluation of its incidence and associated factors

artículo científico publicado en 2015

Fractionated administration of irinotecan and cisplatin for treatment of extensive-disease small-cell lung cancer: a phase II study.

artículo científico publicado en 2003

Gastrobiliary motility is not coordinated in patients with non-ulcer dyspepsia of normal gastric emptying time: simultaneous sonographic study

artículo científico publicado en 2005

Gefitinib ('Iressa', ZD1839) may restore chemosensitivity in NSCLC patients?

artículo científico publicado en 2005

Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol

artículo científico publicado en 2015

Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation.

artículo científico publicado en 2007

Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: results from a prospective feasibility study

artículo científico publicado en 2005

Growth factors temporally associate with airway responsiveness and inflammation in allergen-exposed mice

artículo científico publicado en 2007

Heerfordt's Syndrome Associated with a High Fever and Elevation of TNF-α.

artículo científico publicado en 2016

Hepatocyte growth factor expression in EGFR mutant lung cancer with intrinsic and acquired resistance to tyrosine kinase inhibitors in a Japanese cohort

artículo científico publicado en 2011

High frequency of allele-specific down-regulation of HLA class I expression in lung cancer cell lines

artículo científico publicado en 2004

Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency

artículo científico publicado en 2003

Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells

artículo científico publicado en 2007

Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.

artículo científico publicado en 2005

Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement

artículo científico publicado en 2010

Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer

artículo científico publicado en 2008

Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703.

artículo científico publicado en 2015

Impact of multiple alcohol dehydrogenase gene polymorphisms on risk of upper aerodigestive tract cancers in a Japanese population

artículo científico publicado en 2009

Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations

artículo científico publicado en 2013

Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient

artículo científico publicado en 2016

Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer

artículo científico publicado en 2012

Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis

artículo científico publicado en 2012

Induction chemoradiotherapy prior to surgery for non-small cell lung cancer invading the left atrium

artículo científico publicado en 2007

Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells

artículo científico publicado en 2003

Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP-C promoter

artículo científico publicado en 2008

Influence of altering administration sequence of docetaxel, gemcitabine and cisplatin in patients with advanced non-small cell lung cancer

artículo científico publicado en 2006

Influence of radiofrequency ablation of lung cancer on pulmonary function

artículo científico publicado en 2011

Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response

artículo científico publicado en 2012

Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer

artículo científico publicado en 2011

Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group

artículo científico publicado en 2005

Invasive mucinous adenocarcinoma mimicking organizing pneumonia associated with Mycobacterium fortuitum infection

artículo científico publicado en 2014

Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?

artículo científico publicado en 2018

JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation

artículo científico publicado en 2012

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

scholarly article by Shunichi Sugawara et al published May 2019 in International Journal of Clinical Oncology

Knockdown of the epidermal growth factor receptor gene to investigate its therapeutic potential for the treatment of non-small-cell lung cancers

artículo científico publicado en 2012

LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both

artículo científico

Large cell neuroendocrine carcinoma of the mediastinum

artículo científico publicado en 2010

Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells

artículo científico publicado en 2011

Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis

artículo científico publicado en 2016

Long-term effect of gefitinib (ZD1839) on squamous cell carcinoma of the lung

artículo científico publicado en 2004

Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease

artículo científico publicado en 2017

Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis

artículo científico publicado en 2012

Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer model

artículo científico publicado en 2013

Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy

artículo científico publicado en 2015

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.

artículo científico publicado en 2012

MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors

artículo científico publicado en 2009

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

artículo científico publicado en 2018

Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non-small cell lung cancer: systematic review

artículo científico publicado en 2015

Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer

artículo científico

Medical treatment of mesothelioma: anything new?

artículo científico publicado en 2011

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer

artículo científico publicado en 2004

Molecular oncology of lung cancer

artículo científico

Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.

artículo científico publicado en 2003

Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung

article

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

artículo científico publicado en 2015

Obstructive jaundice at the initial presentation in small-cell lung cancer.

artículo científico publicado en 2010

P1.33: Afatinib Versus Chemotherapy for EGFR Mutation-Positive NSCLC Patients Aged ≥65 Years: Subgroup Analysis of LUX-Lung 3/6: Track: Advanced NSCLC.

artículo científico publicado en 2016

Paradoxical Clinical Effects of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Acute Myelogenous Leukemia

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset

artículo científico publicado en 2018

Phase I study of docetaxel and irinotecan in patients with advanced non-small-cell lung cancer

artículo científico publicado en 2004

Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.

artículo científico publicado en 2005

Phase I/II study of alectinib in lung cancer with RET fusion gene: study protocol

artículo científico publicado en 2017

Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer

artículo científico publicado en 2003

Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403.

artículo científico publicado en 2016

Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer.

artículo científico publicado en 2011

Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.

artículo científico publicado en 2015

Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.

artículo científico publicado en 2010

Pilot Analysis of Asbestos-induced Diffuse Pleural Thickening with Respiratory Compromise

artículo científico publicado en 2015

Pneumocystis Pneumonia Concomitant with Ectopic ACTH Syndrome Caused by a Large Cell Neuroendocrine Carcinoma of the Thymus

artículo científico publicado en 2017

Potential influence of being overweight on the development of hepatic dysfunction in Japanese patients with EGFR-mutated non-small cell lung cancer undergoing gefitinib monotherapy: the Okayama Lung Cancer Study Group experience

artículo científico publicado en 2016

Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations

artículo científico publicado en 2017

Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin

artículo científico publicado en 2008

Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer

artículo científico publicado en 2006

Presentation of Garcin syndrome due to lung cancer

artículo científico publicado en 2007

Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.

artículo científico publicado en 2003

Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines

artículo científico publicado en 2015

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

artículo científico publicado en 2012

Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary Disease

artículo científico publicado en 2017

Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405).

artículo científico publicado en 2016

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

artículo científico publicado en 2012

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab

artículo científico publicado en 2018

Rapid on-site evaluation with BIOEVALUATOR(®) during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing pulmonary and mediastinal diseases

artículo científico publicado en 2014

Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study

artículo científico publicado en 2016

Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy: results of a prospective feasibility study in advanced lung cancer in the Okayama Lung Cancer Study Group Trial 1002.

artículo científico publicado en 2013

Reappraisal of short-term low-volume hydration in cisplatin-based chemotherapy; hoping for it as a public domain

artículo científico publicado en 2015

Recent improvement in lung cancer screening: a comparison of the results carried out in two different time periods

artículo científico publicado en 2006

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

artículo científico publicado en 2007

Relationship between epidermal growth factor receptor gene mutations and the severity of adverse events by gefitinib in patients with advanced non-small cell lung cancer

artículo científico publicado en 2006

Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine

artículo científico publicado en 2008

Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases

artículo científico publicado en 2002

Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials

artículo científico publicado en 2004

Role of early serial change in serum carcinoembryonic antigen levels as a predictive marker for radiological response to gefitinib in Japanese patients with non-small cell lung cancer

artículo científico publicado en 2007

Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review

artículo científico publicado en 2011

STAT3 expression in activating EGFR-driven adenocarcinoma of the lung

artículo científico publicado en 2012

Safety and discomfort during bronchoscopy performed under sedation with fentanyl and midazolam: a prospective study

artículo científico publicado en 2016

Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience

artículo científico publicado en 2005

Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer

artículo científico

Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery

artículo científico publicado en 2018

Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung

scientific article published on April 2008

Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer

artículo científico publicado en 2005

Severe interstitial pneumonia induced by paclitaxel in a patient with adenocarcinoma of the lung.

artículo científico publicado en 2006

Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group experience

artículo científico publicado en 2008

Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201.

artículo científico publicado en 2015

Spontaneous regression of metastatic endometrial stromal sarcoma

artículo científico publicado en 2002

Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer

artículo científico publicado en 2014

Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer

artículo científico publicado en 2011

Study about the Efficacy of Metformin to Immune Function in Cancer Patients

artículo científico publicado en 2016

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

artículo científico publicado en 2012

Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin

artículo científico publicado en 2005

Super scan using positron emission tomography in lung cancer patients

artículo científico publicado en 2007

Synchronous pulmonary MALT lymphoma and pulmonary adenocarcinoma after metachronous gastric MALT lymphoma and gastric adenocarcinoma

artículo científico publicado en 2008

Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells

artículo científico publicado en 2012

Synergistic effect of pacritinib with erlotinib on JAK2-mediated resistance in epidermal gowth factor receptor mutation-positive non-small cell lung Cancer

artículo científico publicado en 2016

Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line.

artículo científico publicado en 2002

Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer

artículo científico publicado en 2005

TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells

artículo científico publicado en 2015

Tandem high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation for recurrent soft tissue sarcoma.

artículo científico publicado en 2002

The Role of STAT3 in Non-Small Cell Lung Cancer

artículo científico

The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor

artículo científico publicado en 2011

The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells.

artículo científico publicado en 2006

The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer

artículo científico publicado en 2007

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

artículo científico publicado en 2005

Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E.

artículo científico publicado en 2017

Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.

artículo científico publicado en 2016

Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JP.

artículo científico publicado en 2017

Thrombocytosis as a useful prognostic indicator in patients with lung cancer

artículo científico publicado en 2004

Time to progression as a surrogate marker for overall survival in patients with advanced non-small cell lung cancer

artículo científico publicado en 2009

Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades

artículo científico publicado en 2012

Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small cell lung cancer: a phase I/II trial.

artículo científico publicado en 2007

Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer

artículo científico publicado en 2010

Triplet therapy with afatinib, cetuximab, and bevacizumab induces deep remission in lung cancer cells harboring EGFR T790M in vivo

artículo científico publicado en 2017

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results

artículo científico publicado en 2009

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer

artículo científico publicado en 2006

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment

artículo científico publicado en 2009

Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen

artículo científico publicado en 2014

Vandetanib is effective in EGFR-mutant lung cancer cells with PTEN deficiency

artículo científico publicado en 2012

Variant angina pectoris associated with FOLFOX4 therapy

artículo científico publicado en 2011

Whole blood interferon-gamma assay for baseline tuberculosis screening among Japanese healthcare students

artículo científico publicado en 2007

[Subset analysis of data in the Japanese patients with NSCLC from IDEAL 1 study on gefitinib].

artículo científico publicado en 2004